Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1417
| Despition | STMN3 Human Recombinant |
| SIZE | 2 µg |
| Purity | > 85.0% (SDS-PAGE) |
| Form | Sterile filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1238 | LIMK1 Blocking Peptide (AC1238) | 250 µg | inquiry |
| ACPP-1630 | Human ENO2 Protein, His (AC1630) | 2 µg | inquiry |
| ACPP-1766 | Human HMGA2 Protein (AC1766) | 2 µg | inquiry |
| ACPP-1519 | Human MANF Protein (AC1519) | 5 µg | inquiry |
| ACPP-1462 | Human CD34 Protein (AC1462) | 5 µg | inquiry |
| ACPP-1335 | Nicotinic Acetylcholine Receptor alpha 7 Blocking Peptide (AC1335) | 250 µg | inquiry |
| ACPP-1843 | Human PON1 Protein (AC1843) | 2 µg | inquiry |
| ACPP-1420 | MOG (AC1420) | 5 mg | inquiry |
| ACPP-1545 | Human YWHAG Protein (AC1545) | 5 µg | inquiry |
| ACPP-1745 | Mouse Acrp30 Protein, His (AC1745) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.